Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Treating acute myeloid leukemia is challenging, especially in older adults, despite some advancements.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

The removal of the adrenal tumor improved the patient's symptoms and reduced androgen levels, indicating successful surgery.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Combining α-blockers with 5α-reductase inhibitors improves symptoms and outcomes for severe benign prostatic hyperplasia.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Cancer treatments often cause skin, nail, and hair problems.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

ONCO-NK-TRANSITION-GM1 is a low-cost, effective cancer treatment with a high cure rate and no severe side effects.

ONCO-NK-TRANSITION-GM1 is a low-cost, effective cancer treatment with a high cure rate and no severe side effects.

The combination of oral minoxidil, oral dutasteride, and mesotherapy is the most effective and safe for hair growth in AGA.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

The combination therapy effectively improved acne keloidalis nuchae.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Upadacitinib effectively treated alopecia areata when other treatments failed.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.